SVRA
Savara Inc
NASDAQ · Healthcare · Biotechnology · US
$4.63
+4.04%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-14.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Parker Braden C. · officer: Chief Commercial Officer | F-InKind | 29,323 | $5.07 |
| Jul 24, 2026 | Lutz Robert Matthew · officer: Chief Fin. & Operating Officer | A-Award | 35,000 | $0.00 |
| Jul 24, 2026 | Lutz Robert Matthew · officer: Chief Fin. & Operating Officer | A-Award | 70,000 | $5.81 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 87,650 | $3.35 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 21,682 | $5.50 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 53,387 | $5.50 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 10,114 | $5.50 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 129,350 | $1.23 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | Sale | 394,528 | $5.68 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 28,928 | $5.50 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 56,937 | $1.11 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 218,750 | $1.51 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 75,000 | $1.59 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 12,500 | $4.45 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 60,057 | $5.50 |
| Jun 22, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 11,491 | $5.50 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 11,037 | $5.04 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 9,485 | $5.04 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 130,650 | $1.23 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 80,684 | $1.51 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 23,661 | $5.04 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 43,063 | $1.11 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 24,850 | $3.35 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 31,885 | $5.04 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 16,518 | $5.04 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | F-InKind | 24,174 | $5.04 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 75,000 | $1.59 |
| Mar 20, 2026 | Lowrance David L · officer: Chief Financial Officer | M-Exempt | 12,500 | $4.45 |
| Feb 17, 2026 | McCracken Joseph S · director | M-Exempt | 1,807 | $1.76 |
| Dec 19, 2025 | RAMSAY DAVID A · director | Sale | 20,000 | $6.06 |
Institutional positioning
13F filings over the trailing two quarters
New 85Increased 128Reduced 98Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 24,471,264 | May 15, 2026 |
| NEA Management Company, LLC | Unchanged | 24,471,264 | Aug 14, 2026 |
| Bain Capital Life Sciences Investors, LLC | Unchanged | 17,600,621 | Aug 14, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Unchanged | 17,600,621 | May 15, 2026 |
| VR Adviser, LLC | Increased | 14,745,943 | Aug 14, 2026 |
| VR ADVISER, LLC | Unchanged | 13,740,375 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 13,569,000 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Unchanged | 13,569,000 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 12,494,498 | Aug 7, 2026 |
| TCG CROSSOVER MANAGEMENT, LLC | Unchanged | 12,362,205 | May 15, 2026 |
| TCG Crossover Management, LLC | Unchanged | 12,362,205 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 11,291,185 | May 13, 2026 |
| Frazier Life Sciences Management, L.P. | Unchanged | 9,720,852 | Aug 14, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Reduced | 9,720,852 | May 15, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 9,541,786 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 25, 2026